Driving Collaboration and Growth: New Chief Executive Officer at Life Sciences Network Organisation
The Brief
In December 2023, Future Leadership partnered with a leading life sciences network organisation to once again appoint a Chief Executive Officer (CEO) to drive and deliver the 2024–2027 strategic plan.
The CEO would be responsible for continuing to build relationships across the health-tech landscape, fostering links and network engagement between members, collaborators, and key decision-makers, including state and federal governments. The Board sought a CEO with knowledge and familiarity with the local healthtech ecosystem and the ability to shape, inspire, and mobilise others around a shared vision for the future. Strong commercial, operational, governance, and financial acumen were critical attributes required to support the organisation’s growth.
Candidate net Promote Score
Future Leadership combines truly personalised relationships with innovative technology solutions to ensure an approachable and efficient process for all our Net Promoter Score across clients, successful candidates and unsuccessful candidates is well above industry standard.
Candidates supported every year
We maintain genuine relationships with past candidates and continue to support them with leadership solutions long term, after they land their role.
Senior Women Appointed since 2002
Over half of the executive search assignments undertaken by our team have resulted in the appointment of outstanding female or LGBTQI+ leaders to high profile roles.
Candidate Retention Rate for 12 months since 2002
Our thorough briefing process and ability to engage passive candidates mean that we go to great lengths to find the right person for the role – long term!
The Process
Future Leadership developed a robust search strategy targeting individuals across a broad range of health and life sciences sectors in both the public and private domains.
A total of 45 applications were received. Following behavioural-based interviews, five candidates completed psychological assessments and were presented to the selection panel. Three candidates progressed to panel interviews, with full referencing conducted on the preferred candidate before submission to the selection panel.
Emerging Capabilities
CE marking
Understanding of CE marking requirements for products, ensuring they meet European safety, health, and environmental protection standards.
CEO/CFO Certification
Certification and qualifications relevant to CEO or CFO roles, demonstrating expertise in executive management and financial oversight.
Trade Compliance
Knowledge of regulations and procedures for compliance with international trade laws and standards.
Product Compliance
Expertise in ensuring products meet regulatory standards and requirements for safety, quality, and performance.
Healthcare
Knowledge and experience in healthcare management, including clinical governance, stakeholder engagement, and improving health outcomes.
The Outcome
The selected candidate, with extensive experience leading complex science-based policy and regulatory environments, was appointed to the role of Chief Executive Officer and commenced in mid-2024.
The new CEO brings nearly 20 years of for-purpose and government experience, having worked in key roles with both local and international organisations, to drive the organisation’s growth and influence within the life sciences sector.
